Genmab AS (GMAB) — Capital Reinvestment Ratio
Genmab AS (GMAB) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow ($300.34 Million) in capital expenditures ($12.99 Million). See Genmab AS (GMAB) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Genmab AS Capital Reinvestment Ratio (2007–2025)
This chart tracks Genmab AS's Capital Reinvestment Ratio across 15 annual periods. Check Genmab AS investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Genmab AS (2007–2025)
Year-by-year Capital Reinvestment Ratio for Genmab AS from 2007 to 2025. For live market cap and broader valuation context, see GMAB company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | $1.19 Billion | $37.03 Million | ▲ +29.6% |
| 2024 | 0.02x | $7.77 Billion | $187.00 Million | ▼ -52.8% |
| 2023 | 0.05x | $7.38 Billion | $376.00 Million | ▼ -37.1% |
| 2022 | 0.08x | $3.91 Billion | $317.00 Million | ▼ -28.4% |
| 2021 | 0.11x | $2.23 Billion | $252.00 Million | ▲ +137.0% |
| 2020 | 0.05x | $6.43 Billion | $307.00 Million | ▼ -43.0% |
| 2019 | 0.08x | $1.33 Billion | $111.00 Million | ▼ -82.2% |
| 2018 | 0.47x | $1.01 Billion | $477.37 Million | ▲ +744.5% |
| 2017 | 0.06x | $1.59 Billion | $88.51 Million | ▼ -44.9% |
| 2016 | 0.10x | $327.72 Million | $33.11 Million | ▼ -76.8% |
| 2015 | 0.43x | $311.45 Million | $135.39 Million | ▼ -23.6% |
| 2014 | 0.57x | $132.67 Million | $75.44 Million | ▲ +348.2% |
| 2012 | 0.13x | $70.92 Million | $9.00 Million | ▲ +236.5% |
| 2010 | 0.04x | $268.17 Million | $10.11 Million | ▲ +48.5% |
| 2007 | 0.03x | $505.90 Million | $12.84 Million | — |